Bergman Simon, Al-Bader Mohammed, Sourial Nadia, Vedel Isabelle, Hanna Wael C, Bilek Aaron J, Galatas Christos, Marek Jonah E, Fraser Shannon A
Department of Surgery, Jewish General Hospital, McGill University, Pavilion A-515, 3755 Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Surg Endosc. 2015 Dec;29(12):3485-90. doi: 10.1007/s00464-015-4098-9. Epub 2015 Feb 12.
The purpose of this study was to determine the proportion of symptomatic recurrence following initial non-operative management of gallstone disease in the elderly and to test possible predictors.
This is a single institution retrospective chart review of patients 65 years and older with an initial hospital visit (V1) for symptomatic gallstone disease, over a 4-year period. Patients with initial "non-operative" management were defined as those without surgery at V1 and without elective surgery at visit 2 (V2). Baseline characteristics included age, sex, Charlson comorbidity index (CCI), diagnosis, and interventions (ERCP or cholecystostomy) at V1. Outcomes assessed over 1 year were as follows: recurrence (any ER/admission visit following V1), surgery, complications, and mortality. A survival analysis using a Cox proportional hazards model was performed to assess predictors of recurrence.
There were 195 patients initially treated non-operatively at V1. Mean age was 78.3 ± 7.8 years, 45.6% were male, and the mean CCI was 2.1 ± 1.9. At V1, 54.4% had a diagnosis of biliary colic or cholecystitis, while 45.6% had a diagnosis of cholangitis, pancreatitis, or choledocholithiasis. 39.5% underwent ERCP or cholecystostomy. Excluding 10 patients who died at V1, 31.3% of patients had a recurrence over the study period. Among these, 43.5% had emergency surgery, 34.8% had complications, and 4.3% died. Median time to first recurrence was 2 months (range 6 days-4.8 months). Intervention at V1 was associated with a lower probability of recurrence (HR 0.3, CI [0.14-0.65]).
One-third of elderly patients will develop a recurrence following non-operative management of symptomatic biliary disease. These recurrences are associated with significant rates of emergency surgery and morbidity. Percutaneous or endoscopic therapies may decrease the risk of recurrence.
本研究的目的是确定老年胆石症患者初次非手术治疗后症状复发的比例,并测试可能的预测因素。
这是一项对一家机构中65岁及以上因症状性胆石症初次住院就诊(V1)的患者进行的为期4年的回顾性图表审查。初次“非手术”治疗的患者定义为在V1时未进行手术且在就诊2(V2)时未进行择期手术的患者。基线特征包括年龄、性别、Charlson合并症指数(CCI)、诊断以及V1时的干预措施(内镜逆行胰胆管造影术或胆囊造瘘术)。在1年期间评估的结果如下:复发(V1后任何急诊室就诊/住院)、手术、并发症和死亡率。使用Cox比例风险模型进行生存分析以评估复发的预测因素。
有195例患者在V1时最初接受非手术治疗。平均年龄为78.3±7.8岁,45.6%为男性,平均CCI为2.1±1.9。在V1时,54.4%被诊断为胆绞痛或胆囊炎,而45.6%被诊断为胆管炎、胰腺炎或胆总管结石。39.5%接受了内镜逆行胰胆管造影术或胆囊造瘘术。排除在V1时死亡的10例患者,31.3%的患者在研究期间出现复发。其中,43.5%接受了急诊手术,34.8%出现并发症,4.3%死亡。首次复发的中位时间为2个月(范围6天至4.8个月)。V1时的干预与较低的复发概率相关(风险比0.3,置信区间[0.14 - 0.65])。
三分之一的老年患者在症状性胆道疾病非手术治疗后会出现复发。这些复发与较高的急诊手术率和发病率相关。经皮或内镜治疗可能会降低复发风险。